Record Collections and Strong YoY Growth
Generated record collections of $245 million in Q4, up 41% year-over-year, driven by deployments in 2023–2024 and portfolio contributions (Conn's contributed $36M and Bluestem $14M in the quarter).
Record Deployments and Growing ERC
Record deployments of $381 million in Q4, up 6% year-over-year; estimated remaining collections (ERC) reached a record $3.4 billion, up 23% year-over-year, with 58% expected to be collected through 2027 and $1.1 billion expected in the next 12 months.
Revenue and Profitability Improvements
Quarterly revenue was a record $155 million, up 30% year-over-year; adjusted EPS of $0.69; adjusted pretax income of $51 million (up 15% YoY) and adjusted cash EBITDA of $178 million (up 34% YoY).
Sector-Leading Operating Efficiency
Delivered a sector-leading cash efficiency ratio of 71% in Q4 (71% aided by Conn's/Bluestem; 68% excluding those portfolios). Full-year 2025 cash efficiency was 74% (69.7% excluding Conn's/Bluestem), reflecting sustained cost-to-collect advantages.
Strong Capital Structure and Liquidity
Amended revolver increased committed capital by $175 million to $1.0 billion, extended tenor, improved pricing (~50 bps) and effective interest savings (~60 bps); net debt to adjusted cash EBITDA improved to 1.9x, below peers; facility had $232M drawn and $300M capacity earmarked for May 2026 bond repayment (bonds pre-funded via $500M unsecured issuance).
Successful Strategic Transactions and Integration
Completed Bluestem acquisition (closed Dec 4) and Conn's portfolio purchase; both integrated with performance in line with expectations and contributed meaningful revenue/NOI (Conn's: $15.5M portfolio revenue, $1.3M servicing revenue, $10.7M NOI; Bluestem: $5.4M revenue, $2.5M NOI).
Capital Allocation and Shareholder Returns
Conducted a follow-on equity offering improving float and reducing J.C. Flowers ownership to 53%; repurchased ~3 million shares (~5%) for $59M as a tactical move; Board declared a regular quarterly dividend of $0.24/share (≈4.7% annualized yield as of February).
Long-Term Growth Track Record
From 2019 through 2025 Jefferson Capital delivered strong multi-year growth: revenue CAGR 27%, net operating income CAGR 37%, and net income CAGR 43%, highlighting sustained profitability and growth through cycles.